Skip to content
Stop using now Drug recall · FDA · Published August 25, 2015

Apotex Recalls Bromfenac Eye Drops Due to Sterility Risk

Apotex recalls specific lots of Bromfenac Ophthalmic Solution 0.09% due to lack of sterility assurance. Check your bottle's NDC and lot number.

🇺🇸 FDA recall #D-0009-2016DrugApotex ›
Take action

Contact the company

Recalling firmApotex Inc.150 Signet Drive · Toronto, Canada
✎ GovInfoNow plain-language explainer

Apotex Inc. is recalling Bromfenac Ophthalmic Solution 0.09% because the product failed preservative effectiveness testing, meaning there is no assurance of sterility. The recall covers specific lots distributed nationwide in bottles of 1.7 mL and 2.5 mL sizes. Consumers should check their medication against the identified lot numbers to see if it is affected. Read more at govinfonow.com/recall/43786-apotex-inc-recalls-bromfenac-ophthalmic-solution-0-09-packaged-in.

Source Summary by GovInfoNow · govinfonow.com/recall/43786-apotex-inc-recalls-bromfenac-ophthalmic-solution-0-09-packaged-in · Updated October 12, 2026 · FDA enforcement record: FDA #D-0009-2016

Cite this page

“Apotex Recalls Bromfenac Eye Drops Due to Sterility Risk.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/43786-apotex-inc-recalls-bromfenac-ophthalmic-solution-0-09-packaged-in. Based on FDA recall #D-0009-2016 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0009-2016%22&limit=1).

Apotex Inc. recalled Bromfenac Ophthalmic Solution 0.09% on August 25, 2015, due to a lack of sterility assurance from failed preservative testing, the FDA said. The recall affects specific lots distributed nationwide.

How to tell if you have it

  • Brand: Apotex
  • Product: Bromfenac Ophthalmic Solution 0.09%
  • NDC 60505-0595-05 (1.7 mL bottle)
  • NDC 60505-0596-04 (2.5 mL bottle)
  • Lot MF0537, Exp 07/2016
  • Lot MF8090, Exp 07/2016
  • Lot MF0532, Exp 07/2016

The hazard

The product failed preservative effectiveness testing, resulting in a lack of assurance of sterility. The FDA classified the recall as Class II.

Context

GovInfoNow's records show Apotex Inc. has 19 other recalls on record since April 30, 2012. Other recent recalls include an Apotex Metformin Tablets Recall for NDMA impurity risk on May 27, 2020, and an Apotex Atorvastatin 40mg Tablets Recall for foreign tablets on October 22, 2019. Similar recent recalls of eye drops include an Apotex Brimonidine/Timolol Eye Drops Recall for sterility risk on March 5, 2026, a Clear Eyes Eye Drops Recalled for sterility risk on July 29, 2026, and a K.C. Pharmaceuticals Recalls Eye Drops due to lack of sterility assurance on March 3, 2026.

How to tell if you have this one

Look for Bromfenac Ophthalmic Solution 0.09% manufactured by Apotex Corp., Weston, FL. Check the label for NDC numbers 60505-0595-05 (1.7 mL bottle) or 60505-0596-04 (2.5 mL bottle). Affected lots are MF0537, MF8090, and MF0532, all with an expiration date of 07/2016.

  • Brand
    Apotex
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop using the medication

    Do not use any eye drops that match the recalled lot numbers or NDC codes listed in the record.

  2. Contact your pharmacist or doctor

    Reach out to where you purchased the medication or your healthcare provider for instructions on replacement or disposal.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 6.8 years after the firm started it.

1. Firm started the recall: Aug 25, 201512. FDA classified it Class II: Oct 9, 201523. Published in FDA’s Enforcement Report: Oct 21, 201534. FDA terminated the recall: Jun 15, 2022420152022
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0009-2016 (August 25, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0009-2016 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA